These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4336308)

  • 1. Pseudohypoparathyroidism. A disease of the second messenger (3',5'-cyclic AMP).
    Greenberg SR; Karabell S; Saade GA
    Arch Intern Med; 1972 Apr; 129(4):633-7. PubMed ID: 4336308
    [No Abstract]   [Full Text] [Related]  

  • 2. Responsiveness of bone to parathyroid extract in siblings with pseudohypoparathyroidism.
    McDonald KM
    Metabolism; 1972 Jun; 21(6):521-31. PubMed ID: 4337585
    [No Abstract]   [Full Text] [Related]  

  • 3. Pseudohypoparathyroidism and related disorders.
    Aurbach GD
    Henry Ford Hosp Med J; 1983; 31(4):233-5. PubMed ID: 6325373
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hormone resistance syndrome: studies on pseudohypoparathyroidism].
    Ogata E
    Nihon Naika Gakkai Zasshi; 1991 Sep; 80(9):1351-5. PubMed ID: 1662253
    [No Abstract]   [Full Text] [Related]  

  • 5. Acquired resistance to parathyroid hormone.
    Sinha TK; Queener SF; Bell NH; Larson S
    Acta Endocrinol (Copenh); 1976 Oct; 83(2):321-3. PubMed ID: 61689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudohypoparathyroidism type II: a possible defect in the reception of the cyclic AMP signal.
    Drezner M; Neelon FA; Lebovitz HE
    N Engl J Med; 1973 Nov; 289(20):1056-60. PubMed ID: 4355058
    [No Abstract]   [Full Text] [Related]  

  • 7. Pseudohypoparathyroidism: defective excretion of 3',5'-AMP in response to parathyroid hormone.
    Chase LR; Melson GL; Aurbach GD
    J Clin Invest; 1969 Oct; 48(10):1832-44. PubMed ID: 4309802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudohypoparathyroidism. Disappearance of the resistance to parathyroid extract during treatment with vitamin D.
    Stögmann W; Fischer JA
    Am J Med; 1975 Jul; 59(1):140-4. PubMed ID: 1138547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on parathyroid hormone, vitamin D and pseudohypoparathyroidism: an example of trail from basic science to clinical practice.
    Ogata E
    Jpn J Med; 1989; 28(1):1. PubMed ID: 2724638
    [No Abstract]   [Full Text] [Related]  

  • 10. Pseudohypoparathyroidism.
    Johns Hopkins Med J; 1982 Sep; 151(3):137-46. PubMed ID: 6287085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudohypoparathyroidism: the molecular basis for hormone resistance--a retrospective.
    Spiegel AM; Levine MA; Marx SJ; Aurbach GD
    N Engl J Med; 1982 Sep; 307(11):679-81. PubMed ID: 6287258
    [No Abstract]   [Full Text] [Related]  

  • 12. Familial pseudohypoparathyroidism without somatic anomalies.
    Winter JS; Hughes IA
    Can Med Assoc J; 1980 Jul; 123(1):26-31. PubMed ID: 6251958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
    Stögmann W
    Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenesis of pseudohypoparathyroidism].
    Stögmann W
    Klin Padiatr; 1973 Mar; 185(2):146-54. PubMed ID: 4735826
    [No Abstract]   [Full Text] [Related]  

  • 15. [Receptor abnormalities and diseases. Pseudohypoparathyroidism].
    Furukawa Y
    Nihon Naika Gakkai Zasshi; 1987 Dec; 76(12):1803-8. PubMed ID: 2836533
    [No Abstract]   [Full Text] [Related]  

  • 16. Deficient guanine nucleotide regulatory unit activity in cultured fibroblast membranes from patients with pseudohypoparathyroidism type I. a cause of impaired synthesis of 3',5'-cyclic AMP by intact and broken cells.
    Levine MA; Eil C; Downs RW; Spiegel AM
    J Clin Invest; 1983 Jul; 72(1):316-24. PubMed ID: 6308048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defect of receptor-cyclase coupling protein in pseudohypoparathyroidism.
    Farfel Z; Brickman AS; Kaslow HR; Brothers VM; Bourne HR
    N Engl J Med; 1980 Jul; 303(5):237-42. PubMed ID: 6247654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of pseudohypoparathyroidism type la complicated with growth hormone deficiency: recovery of growth hormone secretion after vitamin D therapy.
    Kaji M; Umeda K; Ashida M; Tajima T
    Eur J Pediatr; 2001 Nov; 160(11):679-81. PubMed ID: 11760027
    [No Abstract]   [Full Text] [Related]  

  • 19. Stimulation of 1,25-dihydroxyvitamin D production by parathyroid hormone and dibutyryl 3',5'-cyclic AMP in normal subjects, hypoparathyroidism and pseudohypoparathyroidism.
    Unakami H; Furukawa Y; Sohn HE; Yumita S; Miura R; Hanew K; Yoshinaga K
    Tohoku J Exp Med; 1982 Oct; 138(2):167-75. PubMed ID: 6294914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acetazolamide on calcium and phosphate metabolism in type I pseudohypoparathyroidism: interaction with parathyroid hormone.
    Baran DT; Klahr S; Slatopolsky E; Avioli LV
    J Clin Endocrinol Metab; 1979 May; 48(5):766-70. PubMed ID: 219008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.